Abstract: A system for clock management in an m columns×n rows array-based accelerators. Each row of the array may include a clock domain that clocks runtime clock cycles for the m processing elements. The clock domain includes a data detection and timing control circuit which is coupled to a common clock phase bus which provides a local clock source in multiple selectable phases, wherein the data detection and timing control circuit is configured to select a clock phase to clock a next clock cycle for a next concurrent data processing by the m processing elements. Each of m processing elements is coupled to access data from a first memory and a second memory and to generate respective outputs from each of the m processing elements to a corresponding m processing element of a same column in a subsequent neighboring row for the next processing in the next clock cycle.

Abstract: The systems and methods describe a buck regulator, on-chip inductor and/or power management circuits. A buck regulator circuit can include a first switch and a second switch connected with a resonant switching circuit. The resonant switching circuit includes an inductor, a first capacitor and a second capacitor configured to reduce a switching power from a switching frequency of the buck regulator.

Abstract: The disclosed are shelf-stable beta-hydroxyisovaleric acid containing soft gel compositions and methods for making such compositions. In certain aspects, disclosed compositions comprise a plant-based capsule shell and a liquid formulation comprising beta-hydroxyisovaleric acid and at least one excipient, wherein the soft gel capsule is shelf-stable. In certain aspects, the excipient is selected from selected from choline salt, betaine, phosphatidylcholine, alpha-glycerophosphocholine, carnitine, adenosine 5?-triphosphate, or a combination thereof.

Abstract: The disclosed are shelf-stable beta-hydroxyisovaleric acid containing soft gel compositions and methods for making such compositions. In certain aspects, disclosed compositions comprise a plant-based capsule shell and a liquid formulation comprising beta-hydroxyisovaleric acid and at least one excipient, wherein the soft gel capsule is shelf-stable. In certain aspects, the excipient is selected from selected from choline salt, betaine, phosphatidylcholine, alpha-glycerophosphocholine, carnitine, adenosine 5?-triphosphate, or a combination thereof.

Abstract: A method for controlling the movement of an X-ray source via a suspension device includes obtaining, during a movement of the suspension device along the rail, a first speed of the suspension device at the first reference point. The first reference point may correspond to a first target position. The method may also include determining whether the first speed of the suspension device at the first reference point is less than a threshold speed. In response to a result of the determination that the first speed of the suspension device at the first reference point is less than the threshold speed, the method may further include actuating a control device to move the suspension device to the first target position.

Abstract: Disclosed are a class of URAT1 inhibitor compounds and the use of such compounds. These compounds are compounds represented by the structure of formula (I) or pharmaceutically acceptable salts thereof. Experiments show that the compounds provided by the present invention have a very good inhibitory effect on hURAT1-transported uric acid in HEK293 transfected cells, and show that such compounds have a good potential for application in the treatment of hyperuricemia or gout.

Abstract: A method for controlling the movement of an X-ray source via a suspension device includes obtaining, during a movement of the suspension device along the rail, a first speed of the suspension device at the first reference point. The first reference point may correspond to a first target position. The method may also include determining whether the first speed of the suspension device at the first reference point is less than a threshold speed. In response to a result of the determination that the first speed of the suspension device at the first reference point is less than the threshold speed, the method may further include actuating a control device to move the suspension device to the first target position.

Abstract: The present invention belongs to the field of medicinal chemistry. Specifically disclosed is a class of URAT1 inhibitors for promoting uric acid excretion, which are compounds as represented by the structure of formula (I) or pharmaceutically acceptable salts thereof. Experiments show that the compounds provided by the present invention have a very good inhibitory effect on the transport of uric acid by hURAT1 in HEK293 transfected cells, and that such compounds have a good application prospect in the treatment of hyperuricemia or gout.

Abstract: A system includes an ARM core processor, a programmable regulator, a compiler, and a control unit, where the compiler uses a performance association outcome to generate a 2-bit regulator control values encoded into each individual instruction. The system can provide associative low power operation where instructions govern the operation of on-chip regulators or clock generator in real time. Based on explicit association between long delay instruction patterns and hardware performance, an instruction based power management scheme with energy models are formulated for deriving the energy efficiency of the associative operation. An integrated voltage regulator or clock generator is dynamically controlled based on instructions existing in the current pipeline stages leading to additional power saving. A compiler optimization strategy can further improve the energy efficiency.

Abstract: Disclosed are a class of URAT1 inhibitor compounds and the use of such compounds. These compounds are compounds represented by the structure of formula (I) or pharmaceutically acceptable salts thereof. Experiments show that the compounds provided by the present invention have a very good inhibitory effect on hURAT1-transported uric acid in HEK293 transfected cells, and show that such compounds have a good potential for application in the treatment of hyperuricemia or gout.

Abstract: An electronic device may have a housing. The housing may be characterized by a vertical axis and may have housing structures such as cylindrical housing structures with a cylindrical surface. A speaker may be mounted in the housing to provide sound through openings in the housing structures. A visual output device may be mounted in the housing to provide light through openings in the housing structures. The visual output device may include an electrophoretic display, a light-emitting diode display, or other display with an array of pixels that display images or may include other components for emitting light. During operation, voice commands may be received by a microphone in the device and action taken based on the commands and other information. The action taken may include playing sound with the speaker and providing visual output with the visual output device.

Abstract: An electronic device may have a housing. The housing may be characterized by a vertical axis and may have housing structures such as cylindrical housing structures with a cylindrical surface. A speaker may be mounted in the housing to provide sound through openings in the housing structures. A visual output device may be mounted in the housing to provide light through openings in the housing structures. The visual output device may include an electrophoretic display, a light-emitting diode display, or other display with an array of pixels that display images or may include other components for emitting light. During operation, voice commands may be received by a microphone in the device and action taken based on the commands and other information. The action taken may include playing sound with the speaker and providing visual output with the visual output device.

Abstract: The invention discloses a class of compounds for treating or preventing hyperuricemia or gout, which is a compound shown in general formula (I) or a pharmaceutically acceptable salt. These compounds and their pharmaceutically acceptable salts in the invention are useful for the promotion of uric acid excretion to treat or prevent hyperuricemia or gout.

Abstract: Time domain signal processing (TDSP) encodes information into time rather than voltage with high efficiency. Circuit level design techniques can also reduce the area and energy consumption of TDSP. Design examples on both conventional signal processing blocks and emerging facial recognition applications can be used to demonstrate the potential of the techniques. On a 45 nm CMOS technology, more than about 45% area and energy reduction can be simultaneously achieved from TDSP compared with standard CMOS techniques in emerging applications.

Abstract: An electronic device may have a housing. The housing may be characterized by a vertical axis and may have housing structures such as cylindrical housing structures with a cylindrical surface. A speaker may be mounted in the housing to provide sound through openings in the housing structures. A visual output device may be mounted in the housing to provide light through openings in the housing structures. The visual output device may include an electrophoretic display, a light-emitting diode display, or other display with an array of pixels that display images or may include other components for emitting light. During operation, voice commands may be received by a microphone in the device and action taken based on the commands and other information. The action taken may include playing sound with the speaker and providing visual output with the visual output device.

Abstract: The systems and methods describe a buck regulator, on-chip inductor and/or power management circuits. A buck regulator circuit can include a first switch and a second switch connected with a resonant switching circuit. The resonant switching circuit includes an inductor, a first capacitor and a second capacitor configured to reduce a switching power from a switching frequency of the buck regulator.

Abstract: The invention discloses a class of compounds for treating or preventing hyperuricemia or gout, which is a compound shown in general formula (I) or a pharmaceutically acceptable salt. These compounds and their pharmaceutically acceptable salts in the invention are useful for the promotion of uric acid excretion to treat or prevent hyperuricemia or gout.

Abstract: A system for offsetting a CNC machining process includes transferring compensation variables through registers in fixed G-code programming of the CNC machine and offsetting the CNC machine without altering fixed G-code programming. Global compensation variables are applied to all feature programs of the CNC machining process, and local compensation variables are applied to only individual features or groups of features. The machine shifts position in response to the compensation variables.

Abstract: A method for controlling the movement of an X-ray source via a suspension device includes obtaining, during a movement of the suspension device along the rail, a first speed of the suspension device at the first reference point. The first reference point may correspond to a first target position. The method may also include determining whether the first speed of the suspension device at the first reference point is less than a threshold speed. In response to a result of the determination that the first speed of the suspension device at the first reference point is less than the threshold speed, the method may further include actuating a control device to move the suspension device to the first target position.

Abstract: A lower limb rehabilitation training robot is provided, which includes a bedstead support and a rising bedstead arranged on the bedstead support, and further includes a linear motion device, a push rod device, a bionic leg arranged at one end of a surface of the rising bedstead and hinged to the rising bedstead, and a bed board configured to support a patient and arranged at another end of the rising bedstead. The linear motion device is arranged between the bedstead support and the rising bedstead, is configured to allow the rising bedstead to slide along the bedstead support, and has one lateral surface connected to the bedstead support and another lateral surface hinged to the rising bedstead. The push rod device is configured to drive the rising bedstead to rotate around a hinge point where the rising bedstead is hinged to the linear motion device.